Unlike CYP1B1 and CYP2E1—two other notable P450 enzymes that, while expressed in various cancers, including pediatric STSs [31], are also present in corresponding normal tissues—CYP2W1 appears to be exclusively upregulated in tumor tissues, making it a uniquely selective therapeutic target. This evidence concerns the gene CYP2B6 and neoplasm.